EdgeCap Partners, a provider of private and venture capital investments, completed the acquisition of a majority stake in Comac Medical, a provider innovative and non-conventional solutions of high quality for unmet pharmaceutical industry needs. Financial terms were not disclosed. “We are excited to invest in Comac Medical, which over the past 25 years has grown under Milen’s leadership into an outstanding business that customers overwhelmingly praise for its quality of service, deep medical expertise in early phase clinical development as well as its speed and agility, specifically with regards to patient recruitment across therapeutic areas and rare indications. We think Comac is uniquely positioned to capitalise on the CRO market’s favourable growth prospects and untapped potential,” Christopher Backes, EdgeCap Co-founder.